:: Library Catalog

Image de couverture de livre

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Liao Hangyu, Pan, Mingxin, Zhao, Liang
Format:	Recurso digital
Langue:
Publié:	Zenodo 2026
Accès en ligne:	https://doi.org/10.5281/zenodo.19396187
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Steroid‐Refractory Cryptogenic Organising Pneumonia ( COP ) in a Patient With Mannose‐Binding Lectin ( MBL ) Deficiency
par: Ilias E. Dimeas, et autres
Publié: (2026)

Analysis of Mannose‐Binding Lectin Protein and mRNA Levels on Selected Chicken Breeds in South Africa
par: Peter Ayodeji Idowu, et autres
Publié: (2024)

The TRIM27 / STING Axis Mediates Schisandrin B‐Induced Inhibition of Myeloid‐Derived Suppressor Cells Accumulation to Potentiate Anti‐ PD ‐1 Immunotherapy in Hepatocellular Carcinoma
par: Lei Huang, et autres
Publié: (2026)

Targeting Caveolin‐1 in Multiple Myeloma Cells Enhances Chemotherapy and Natural Killer Cell‐Mediated Immunotherapy
par: Dewen Zhan, et autres
Publié: (2024)

Natural Killer Cells: Angels and Devils for Immunotherapy
par: Martin Antonio, Beatriz, et autres
Publié: (2017)

m 6 A‐Mediated TMCO3 Promotes Hepatocellular Carcinoma Progression by Facilitating the Membrane Translocation and Activation of AKT
par: Xinxin Li, et autres
Publié: (2025)

Transparency and Reporting in the Evaluation of PD1 by Flow Cytometry
par: Marc Sorigue, et autres
Publié: (2025)

Aligned Fibronectin Microenvironment Temporally Facilitates Profibrotic Fibroblast Activation via Integrin α5β1
par: Doğuhan Beyatlı, et autres
Publié: (2026)

Elemene Augments the Effects of Anti‐PD‐1 Immunotherapy on Hepatocellular Carcinoma by Regulating the miR‐130a‐5p/SPP/MHC‐I Axis
par: Menglan Wang, et autres
Publié: (2026)

T Cell Exhaustion in Hepatocellular Carcinoma: A Substantial Barrier in Immunotherapy
par: Kosar Nouri, et autres
Publié: (2026)

Biomimetic Nanomedicine for Senescence‐Modulated Immune Activation Enhances Immunotherapy Efficacy in Hepatocellular Carcinoma
par: Shiji Fang, et autres
Publié: (2025)

Antibody‐Targeted Artificial T Cell and Natural Killer Cell Derived Vesicles for Cancer Immunotherapy
par: Brijesh Parlekar, et autres
Publié: (2026)

Integrin β4‐Enriched Small Extracellular Vesicle as Drug Delivery Vehicle for Targeting Pulmonary Metastasis of Hepatocellular Carcinoma
par: Tung Him Ng, et autres
Publié: (2025)

Clinical Significance of PD ‐ L1 and HLA Expression in Esophageal Squamous Cell Carcinoma in Response to Immunotherapy
par: Kosuke Kanemitsu, et autres
Publié: (2026)

Restricted Expression of the Constant Region 1 of T‐Cell Receptor β by Flow Cytometry Facilitates Detection of T‐Cell Neoplasms With High Specificity but Moderate Predictive Value
par: Nilofar Rajabian, et autres
Publié: (2025)

Variantes del gen Mannose Binding Lectin (MBL) en pobladores amazónicos de Andoas-Loreto y su posible implicancia en la salud
par: Alberto Salazar Granara
Publié: (2006)

PLAUR + Neutrophils Drive Anti‐PD‐1 Therapy Resistance in Patients with Hepatocellular Carcinoma by Shaping an Immunosuppressive Microenvironment
par: Shaoqing Liu, et autres
Publié: (2025)

Nanoparticle‐Mediated Explosive Anti‐PD‐L1 Factory Built in Tumor for Advanced Immunotherapy
par: Mihyeon Park, et autres
Publié: (2025)

LncRNA FGD5‐AS1 Facilitates Hepatocellular Carcinoma Cell Stemness by Enhancing PKD1 mRNA Stability Through Binding With MSI2
par: Chenkun He, et autres
Publié: (2025)

RETRACTION: The Cell Surface GRP78 Facilitates the Invasion of Hepatocellular Carcinoma Cells
par: BioMed Research International
Publié: (2025)

Targeting Intratumoral Copper Inhibits Tumor Progression via p62‐Mediated EZH2 Degradation and Potentiates Anti‐PD‐1 Immunotherapy in Oral Squamous Cell Carcinoma
par: Xiaohu Lin, et autres
Publié: (2025)

Deciphering the Interference of the Anti‐Integrin α4β7 Vedolizumab With Cell Crossmatch
par: Marine Cargou, et autres
Publié: (2025)

Supplementary mateirials for 'PPIL1 Drives Hepatocellular Carcinoma Progression and Cancer Stem Cell Self-Renewal through DAAM2-Mediated Wnt/β-Catenin Activation'
par: Wu, Jiayi
Publié: (2026)

Astragaloside IV Enhances Anti‐PD‐L1 Immunotherapy in Triple‐Negative Breast Cancer by Activating the cGAS‐STING Pathway
par: Chuanchao Wei, et autres
Publié: (2026)

Effects of Splenectomy on Natural Killer Cell Levels in β‐Thalassemia Major Patients
par: Ayşegül Uğur Kurtoğlu, et autres
Publié: (2024)

PD‐L1 on Tumor‐Derived Extracellular Vesicles Induces CD8 + T Cell Terminal Exhaustion and Mediates Anti‐PD‐1 Resistance in Head and Neck Squamous Cell Carcinoma
par: Ruihua Fang, et autres
Publié: (2025)

Light‐Controlled Bioorthogonal Chemistry Altered Natural Killer Cell Activity for Boosted Adoptive Immunotherapy
par: Zhengwei Liu, et autres
Publié: (2024)

Treatment Patterns and Clinical Outcomes After Immunotherapy Failure in Patients With Natural Killer/T‐Cell Lymphoma
par: Shenrui Bai, et autres
Publié: (2026)

Light‐Controlled Bioorthogonal Chemistry Altered Natural Killer Cell Activity for Boosted Adoptive Immunotherapy
par: Zhengwei Liu, et autres
Publié: (2024)

NQO1/p65/CXCL12 Axis‐Recruited Tregs Mediate Resistance to Anti‐PD‐1 Plus Lenvatinib Therapy in PIVKA‐II‐Positive Hepatocellular Carcinoma
par: Biao Gao, et autres
Publié: (2025)

Integrated Computational Modelling and Proteomic Profiling of Banana Lectin Isoforms Recognizing Cancer-Associated High-Mannose N-Glycans
par: Kurniawan, Hansley
Publié: (2026)

Selective Suppression of Integrin‐Ligand Binding by Single Molecular Tension Probes Mediates Directional Cell Migration
par: Seong‐Beom Han, et autres
Publié: (2024)

MMRN1 Facilitates Renal Cell Carcinoma by Activating AMPK / MMPs Axis
par: Mingji Ye, et autres
Publié: (2025)

Natural Killer Cell‐Mediated Antitumor Immunity: Molecular Mechanisms and Clinical Applications
par: Nanzhi Luo, et autres
Publié: (2025)

Y‐Box‐Binding Protein 1 Facilitates the Proliferation and Osteogenic Differentiation of Periodontal Ligament Stem Cells Through the Transcriptional Activation of FGF2 ‐Mediated Akt/ GSK3β /β‐Catenin Signaling
par: Yun‐Hao Xi, et autres
Publié: (2025)

Targeted Therapy and Immunotherapies in Hepatocellular Carcinoma: Mechanisms and Clinical Studies
par: Penghui He, et autres
Publié: (2026)

Gut Microbiota and Hepatocellular Carcinoma: Metabolic Products and Immunotherapy Modulation
par: Kunmin Xiao, et autres
Publié: (2025)

Icaritin Sensitizes Hepatocellular Carcinoma to PD ‐ L1 Therapy by NQO1 ‐Dependent Ferroptosis Induction
par: Zhen Li, et autres
Publié: (2026)

Activatable Fluorescence/Photoacoustic Macromolecular Probe for Imaging of Tumor‐Associated Natural Killer Cells
par: Yanbin Feng, et autres
Publié: (2025)

Mannose Promotes β‐Amyloid Pathology by Regulating BACE1 Glycosylation in Alzheimer's Disease
par: Chensi Liang, et autres
Publié: (2025)